Janus Henderson Biotech Innovation Master Fund Ltd
SEC CIK 2030299 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ORKA | Oruka Therapeutics, Inc. | 10% | 2.12M | $1.44M | — | 2 | 2024-07-03 | 2024-08-16 |
Most active insiders at ORKA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Fairmount Funds Management LLC | Dir, 10% | — | $300.01M |
| 2 | Dambkowski Carl | Dir | — | $8.65M |
| 3 | Klein Lawrence Otto | CEO, Dir | — | $7.31M |
| 4 | Quinlan Paul T | GC | — | $6.76M |
| 5 | Goncalves Joana | Chief Medical Off | — | $4.54M |
| 6 | Agarwal Arjun | SVP, Fin | — | $4.33M |
| 7 | Sandler Laura Lee | COO | — | $1.94M |
| 8 | Edwards Larry Todd | Chief Commercial Off | — | — |
Janus Henderson Biotech Innovation Master Fund Ltd made no open-market trades at ORKA in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-08-20 | 2024-08-16 | ORKA | Oruka Therapeutics, Inc. | Janus Henderson Biotech Innovation Master Fund Ltd | 10% | P - Purchase | $2.93 | +5,818 | 2.12M | +0.3% | +$17.1K |
| MI | 2024-07-12 | 2024-07-03+ | ORKA | Oruka Therapeutics, Inc. | Janus Henderson Biotech Innovation Master Fund Ltd | 10% | P - Purchase | $3.49 | +408.8K | 1.72M | +31% | +$1.43M |
Purchase Sale Sale after option exercise All abbreviations